Skye Bioscience, Inc. (SKYE)
1.86
+0.08
(+4.49%)
USD |
NASDAQ |
Sep 04, 15:04
Skye Bioscience Net Income (TTM) : -50.49M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -50.49M |
| March 31, 2026 | -57.33M |
| December 31, 2025 | -55.92M |
| September 30, 2025 | -51.23M |
| June 30, 2025 | -42.37M |
| March 31, 2025 | -32.65M |
| December 31, 2024 | -26.57M |
| September 30, 2024 | -21.24M |
| June 30, 2024 | -42.29M |
| March 31, 2024 | -37.50M |
| December 31, 2023 | -37.64M |
| September 30, 2023 | -43.12M |
| June 30, 2023 | -21.30M |
| March 31, 2023 | -21.61M |
| December 31, 2022 | -19.48M |
| September 30, 2022 | -12.10M |
| June 30, 2022 | -10.80M |
| March 31, 2022 | -9.405M |
| December 31, 2021 | -8.522M |
| September 30, 2021 | -7.512M |
| June 30, 2021 | -6.983M |
| March 31, 2021 | -6.380M |
| December 31, 2020 | -6.561M |
| September 30, 2020 | -0.2065M |
| June 30, 2020 | -3.841M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.48M |
| December 31, 2019 | 1.052M |
| September 30, 2019 | -10.02M |
| June 30, 2019 | -7.188M |
| March 31, 2019 | -25.75M |
| December 31, 2018 | -19.19M |
| September 30, 2018 | -13.60M |
| June 30, 2018 | -11.98M |
| March 31, 2018 | -10.02M |
| December 31, 2017 | -3.094M |
| September 30, 2017 | -3.587M |
| June 30, 2017 | -4.052M |
| March 31, 2017 | -2.776M |
| December 31, 2016 | -3.178M |
| September 30, 2016 | -2.749M |
| June 30, 2016 | -2.986M |
| March 31, 2016 | -5.616M |
| December 31, 2015 | -4.841M |
| September 30, 2015 | -5.853M |
| June 30, 2015 | -5.528M |
| March 31, 2015 | -3.485M |
| December 31, 2014 | -2.571M |
| September 30, 2014 | -0.8736M |
| April 30, 2014 | -0.0158M |
| January 31, 2014 | -0.0002M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.329B |
| Viking Therapeutics, Inc. | -534.80M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |